The Indianapolis Business Journal (IBJ) hosted the IBJ Life Science Power Breakfast Series this morning at the Marriott Hotel downtown Indianapolis. It was a great panel discussion with industry leaders and well represented by many of the regional life sciences companies and service providers, including (and proud sponsors) Pearl Pathways’ CEO Diana Caldwell and Director, Business Development Chad Pannucci. In addition to an interesting presentation and panel discussion, we enjoyed conversation and getting better acquainted with some of our life science clients & colleagues from Indiana startups, universities and industry experts hosted at the Pearl Pathways table. The impact of the Indiana life science industry cannot be overstated. As mentioned, the output by Indiana life science companies (#medical device, #pharmaceutical, #biotech, #diagnostic etc) represents a $59B per year economic impact and almost $10B in worldwide annual exports where 1 out of every 10 Hoosiers (or ~56,000) work in the life sciences sector. There is tremendous innovation happening right now at places like Purdue University where current president and former State of Indiana governor Mitch Daniels have done a tremendous job to accelerate innovation by creating a framework to spin up startup companies and pursue licensing opportunities with Purdue based research and intellectual property (IP). For example, Purdue recently gained national press and media coverage when researchers recently deciphered the structure of the #Zika virus which will help to more quickly identify and develop therapeutics to treat it, while #GE and #Rolls Royce announced significant multi-year and multi-million dollar investments to further their partnership with the university and leverage engineering talent and facility capabilities to develop and built out new technologies related to jet engine research and advanced manufacturing. Closer to Indianapolis mentioned was the 16 Tech project which will be anchored by the new $250M Indiana Bioscience Research Institute on 60 acres of land situated just northwest of downtown along Indiana Avenue between Indiana University School of Medicine, IUPUI and downtown Indianapolis, not to mention only 20 minutes from the Indianapolis International airport. 16 Tech will be designed as an #innovation hub and a conduit between life sciences research institutions, industry, expertise and facilities to foster and speed development of new products and technologies for medical innovation in Indiana. Events like the IBJ Life Science Power Breakfast Series are important to showcase the progress we have collectively contributed as a state under the guise of not just as a national, but a global effort to push forward technology and breakthrough medical advances to help patients around the world.
Pearl Pathways’ Director of Business Development, Pannucci one of select group of Indianapolis area life science industry executives to make up the ICBI Advisory Council
INDIANAPOLIS, INDIANA – March 23, 2016 – Pearl Pathways’ Director of Business Development, Chad Pannucci was selected as an Advisory Council Member for the new Indiana Council for Biomedical Innovation (‘ICBI’). Pearl Pathways’ President and CEO Diana Caldwell, shares “We are so proud that Chad will be representing Pearl to the life science community and sharing his expertise and knowhow with area startups and entrepreneurs.”
The ICBI recognized a select group of life science and industry executives to bring expertise, mentoring, networking and experience to fledgling entrepreneurs and startup companies. On March 15, 2016, the ICBI held its official grand opening ribbon cutting ceremony at their newly renovated space in Noyes Pavilion at Methodist Hospital on Indianapolis’ near northwest side.
To read the full press release, click here.
On February 17-18, 2016 the Diversity Alliance for Science (DA4S) conference will be held at the Marriott Long Beach Airport Hotel, in Long Beach, CA. DA4S is a non-profit organization focused on supporting, developing, and connecting with a diverse group of suppliers in the Life Science, Pharmaceutical, Bio-Tech, and Healthcare Industries Click here to register. To learn more about DA4S click here.
Pearl Pathways continues to be a proud sponsor of the 2015-2016 Indiana Life Sciences Collaboration Conference Series, presented by the Kelley School’s Center for the Business of Life Sciences. It is an excellent forum that brings together key players in Indiana’s life science and healthcare arenas for intriguing business discussions on business strategy, solutions and development to promote growth.
Diana Caldwell, President and CEO of Pearl Pathways, shares that “The conferences add value for all of the major life science players in the state. It’s a great means to get us together, hear relevant topics from thought leaders, stay up to date, and network.”
Please joins us for the first conference of the year — The Continuing Disruption of Healthcare and Life Sciences Business Models for panel discussions on Changes in Healthcare and Medical Products “Space” and The Future of Medical Products in an Era of Reform: Implications of Value and Consumerism.
What: The Continuing Disruption of Healthcare and Life Sciences Business Model
Where: One America Tower, One American Square, Indianapolis
When: February 19, 2016
A great way to start 2016, please click here to register, and put this important date on your calendar. You may learn more about the Indiana Life Sciences Collaboration Conference Series at this link.
Pearl Pathways is excited to announce its’ participation in the Purdue Economic Gardening Program. The Economic Gardening program is managed by the Purdue Center for Regional Development with funding provided from a gift from the Lilly Endowment Inc.
The Purdue Economic Gardening Program provides tailored assistance to second-stage companies. Four focus areas of the program include providing information that helps companies define core business strategies, delivering market intelligence, assisting in efforts to identify qualified leads, and contributing to the company’s leadership development. Purdue collaborates with the businesses to work through barriers and develop new methods.
To read the full press release, click here.
Pearl Pathways is excited to announce its growth and expansion into a second location in College Station, Texas. The new office will be a part of The Garage, located within the Texas A&M Institute for Preclinical Studies (TIPS) building. The Garage is supported through the relationship of the Research Valley Partnership and its Research Valley Innovation Center in collaboration with Texas A&M University’s Office for the Vice President of Research.
President and CEO of Pearl Pathways, Diana Caldwell, commented “The Research Valley Partnership is promoting unique, world-class cGLP and cGMP infrastructure and capabilities in Bryan-College Station to support startup life science medical device and biopharma companies, which is a core client segment for Pearl,”
To read the full press release, click here.
On October 29, the Indiana Medical Device Manufacturers Council (IMDMC) is hosting their annual conference. Governor Mike Pence will be attending as the keynote speaker. There is still time to register for a booth or sponsorship. Make sure to stop by Pearl Pathways’ booth. For more event information, click here.
Due to the Nazi practice of testing on humans, the Nuremburg Code was created after WWI to ensure that experimenting applies to animals before humans. While alternatives to animal testing have since been created, there are many reasons why they are not commonly used. These alternatives lack funding and require faster validation, while some are known to create false positive results. Some laws allow for the use of alternatives, but expenses end up equating that of animal testing, providing a disincentive to the research companies. According to Marjolein Weda, Dutch National Institute of Public Health and the Environment, the two main reasons for unpopular alternatives are cost and complexity. PETA and other animal rights organizations are fighting for an increase in use of alternatives. Visit Outsourcing-Pharma to read Gareth MacDonald’s full article.
Clinical research professional and former Covance Global Project Manager, Mary Anne Gfell, joins Pearl Pathways.
Bringing over 15 years of experience in clinical research and quality compliance, Gfell is a key addition to the Pearl Pathways team. Prior to joining Pearl Pathways, she worked as a Global Project Manager at Covance, a multi-national CRO where she managed central laboratory services for Phase 1 through 4 clinical global studies. Gfell has extensive expertise in both drug and device trials, and started her career in a clinical setting as a Med Tech. She has further expertise in the creation and oversight of quality systems as well as the development of clinical protocols.
Gfell is an active Certified Clinical Research Coordinator (CCRC), a member of the Association for Clinical Research Professionals (ACRP), and holds her project management certification.
To read full press release, click here.
On September 10th, the second part of the Indiana Medical Device Manufacturers Council two-day program, REG 102, will be hosted.
This program is designed to provide industry background and knowledge specific to FDA regulations to those who may be new to the industry or regulatory function. Pearl Pathways’ own, John Lockwood, will be speaking on inspections.
When: Thursday, September 10, 2015, 8:00 AM to 4:30 PM EDT
Where: The Montage (8580 Allison Pointe Boulevard, Indianapolis, IN 46250)